Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jessica Ribeiro, Gomes"'
Publikováno v:
Journal of Clinical Oncology. 38:e22032-e22032
e22032 Background: The checkpoint inhibitors are effective in the treatment of many types of neoplasia, either being used separately or in combination. Ipilimumab pioneered the treatment of metastatic melanoma and nowadays it has being used in combin
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 41(7)
A 69-year-old man with metastatic lung adenocarcinoma presented with pericarditis and pericardial tamponade during nivolumab treatment, despite near-complete response on images performed during response evaluation. Further investigation found no evid
Publikováno v:
OncoTargets and therapy
Jéssica Ribeiro Gomes, Marcelo Rocha S Cruz Antonio Ermirio de Moraes Oncology Center, São Paulo-Brazil Abstract: Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth factor receptor (EGFR) have shown effectiveness for advanced non-smal
Autor:
Jessica Ribeiro Gomes, Fernando Cotait Maluf, Mauricio Simões Abrão, Filomena Marino Carvalho
Publikováno v:
Gynecologic Oncology Reports
Gynecologic Oncology Reports, Vol 15, Iss C, Pp 22-24 (2016)
Gynecologic Oncology Reports, Vol 15, Iss C, Pp 22-24 (2016)
Uterine tumors with sex-cord elements are very rare. Clement and Scully described 14 patients in 1976 (Clement and Scully, 1976). The authors divided these tumors into two groups: one corresponding to endometrial stromal neoplasms with focal areas re
Autor:
Antonio C. Buzaid, Robson Ferrigno, Jessica Ribeiro Gomes, Pedro Zanuncio, Rafael Schmerling, Erlon Gil, Douglas Racy, Carolina Kawamura Haddad
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 39(9)
Abscopal effect is a rare phenomenon characterized by tumor regression of untreated metastatic lesions after a local therapy (eg, radiotherapy). We studied the probability of abscopal effect with radiotherapy associated with anti-programmed death cel
Autor:
Aline, da Rocha Lino, Carina Meira, Abrahão, Raphael Moreira, Brandão, Jessica Ribeiro, Gomes, Andrea Malta, Ferrian, Marcel Cerqueira César, Machado, Antonio Carlos, Buzaid, Fernando Cotait, Maluf, Renata D'Alpino, Peixoto
Publikováno v:
Journal of gastrointestinal oncology. 6(5)
Cancer of the exocrine pancreas is a highly lethal malignancy. Surgical resection is the only potentially curative treatment. Unfortunately, because of the late presentation, the majority have either locally advanced cancer at initial diagnosis. Syst
Autor:
Diocesio Alves Pinto de Andrade, Noelle Suemi Wassano, Luiza Damian Ribeiro Barbosa, Jessica Ribeiro Gomes, Marcelo Rocha Cruz, Virginia Moreira Braga, Jessica Sayuri Tsukamoto
Publikováno v:
Journal of Clinical Oncology. 35:e18045-e18045
e18045 Background: In the neoadjuvant setting (NAC) of HER2-positive breast cancer (BC), the addition of pertuzumab (P) to trastuzumab (T) and chemotherapy (chemo) has increased pathological complete response (pCR) from 40-50% to over 70%. Recent dat
Autor:
Matheus Bongers Alessandretti, Jessica Ribeiro Gomes, Marcelo Rocha Cruz, Raphael Brandao Moreira
Publikováno v:
Journal of Clinical Oncology. 35:e23166-e23166
e23166 Background: Treatment for metastatic breast cancer (MBC) has been driven by hormone receptors, HER2 expressions or their absence. Resistance to therapy and progressive disease will occur and empirical chemotherapy lines usually are the next st
Autor:
Jessica Ribeiro Gomes
Publikováno v:
Journal of Clinical Oncology. 35:e21044-e21044
e21044 Background: Recently observational and retrospective studies have been observing a higher incidence of melanoma among patients with over normal body mass index (BMI), as well as a higher melanoma-specific mortality. However, no study has analy
Autor:
Jessica Sayuri Tsukamoto, Jessica Ribeiro Gomes, Renata D'Alpino D'Alpino, Matheus Bongers Alessandretti
Publikováno v:
Journal of Clinical Oncology. 34:e21534-e21534
e21534Background: Despite being the standard first-line therapy for patients with advanced pancreatic cancer and good performance status (PS), there are no data regarding efficacy and safety of FOL...